Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Cardiovascular Diseases 2Cardiotoxicity 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Multiple Myeloma 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Leukemia 1Kidney Neoplasms 1Hodgkin Disease 1

Interventions

fludarabine phosphate 4Cyclophosphamide 4fludarabine 3Mesna 3Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Melphalan 2Busulfan 2ibrutinib 1Social Determinants of Health 1Receptors, Chimeric Antigen 1Leukapheresis 1Immunotherapy, Adoptive 1Bone Marrow Transplantation 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Lymphoid × Social Determinants of Health × Clear all
NCT05871008 2025-09-15

Integrated Actionable Aging Assessment for Cancer Patients Pilot

University of Colorado, Denver

Phase NA Active not recruiting
35 enrolled
BreastGenitourinaryLymphoidOther hematologic neoplasmPlasma cell

Urinary Bladder Neoplasms, Breast Neoplasms, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡